Skip to main content

XWEL

Equity

XWELL, Inc.

Health Care · Diagnostics & Research

$1.49

+1.49 (+0.00%)

Open

N/A

Day Range

$1.45 - $2.20

52W Range

$0.26 - $2.20

Volume

68M

Price History

Key Statistics

Market Cap

N/A

P/E Ratio

N/A

EPS

N/A

Dividend Yield

N/A

P/B Ratio

N/A

Payout Ratio

N/A

ROE

N/A

Debt/Equity

N/A

Insider Activity

Date Insider Type Shares Value
Aug 1, 2025

ERNST EZRA

Chief Executive Officer

Other 70,000 $0.0
Aug 1, 2025

ERNST EZRA

Chief Executive Officer

Other 70,000 $0.0
Jun 2, 2025

WEINSTEIN ROBERT

Director

Other 107,407 $0.0
Jun 2, 2025

LEBOWITZ MICHAEL

Director

Other 98,148 $0.0
Jun 2, 2025

WIZENBERG GAEELLE SANDRA

Director

Other 89,198 $0.0
Jun 2, 2025

WEINSTEIN ROBERT

Director

Other 107,407 $0.0
Jun 2, 2025

BERNSTEIN BRUCE G

Director

Other 200,926 $0.0
Jun 2, 2025

LEBOWITZ MICHAEL

Director

Other 98,148 $0.0
Jun 2, 2025

WIZENBERG GAEELLE SANDRA

Director

Other 89,198 $0.0
Jun 2, 2025

BERNSTEIN BRUCE G

Director

Other 200,926 $0.0

Institutional Ownership

15.1% Institutional 16.4% Insider 68.5% Public
Holder Shares % Held Value
Blackrock Inc. 82,693 1.43% $123.2K
Vanguard Group Inc 77,073 1.34% $114.8K
Geode Capital Management, LLC 45,611 0.79% $68.0K
Susquehanna International Group, LLP 33,220 0.58% $49.5K
Citadel Advisors Llc 22,086 0.38% $32.9K
State Street Corporation 16,144 0.28% $24.1K
Xtx Topco Ltd 11,975 0.21% $17.8K
Integrated Wealth Concepts LLC 10,350 0.18% $15.4K
Ground Swell Capital, LLC 10,206 0.18% $15.2K
Citigroup Inc. 8,133 0.14% $12.1K

Peers in Health Care

Symbol Name Price Mkt Cap Div Yield Change
ABCL AbCellera Biologics Inc. $3.61 N/A - +0.00%
ACAD ACADIA Pharmaceuticals Inc. $24.56 N/A - +0.00%
AKBA Akebia Therapeutics, Inc. $1.31 N/A - +0.00%
ABBV AbbVie Inc. $232.08 N/A 2.87% +0.00%
ACB Aurora Cannabis Inc. $3.84 N/A - +0.00%
ABT Abbott Laboratories $116.35 N/A 2.06% +0.00%
A Agilent Technologies, Inc. $121.38 N/A 0.82% +0.00%
AHCO AdaptHealth Corp. $9.15 N/A - +0.00%

Community Sentiment

Sign in to vote

0% Bullish 0% Neutral 100% Bearish

0 votes

Discussion (0)

Sign in to join the discussion

Loading comments...

About XWELL, Inc.

XWELL, Inc. provides health and wellness services to travelers in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment provides traveler's spa services, including massage, and nail and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests to airport employees and traveling public at XpresCheck Wellness Centers in airports; operates the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. The Treat segment provides access to wellness services for travelers at on-site centers. The company offers its services through stores and kiosks, as well as online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.

www.xwell.com →

🐂 Bull Score

Our proprietary rating measures dividend reliability based on 6 fundamental factors including payout sustainability, financial strength, and cash flow coverage.

F 0/100

Very Risky

Bull Score

- No consecutive dividend growth 0/25
- Negative profit margin 0/15
Limited data — score may change as more metrics become available

Dividend Safety

Assessment based on payout ratio, debt levels, profit margins, and dividend growth track record.

35

Unsafe

Based on 4 fundamental factors

- Negative profit margin

Share